价格

Kern Pharma S.L.

Dominican Republic

概览

试验阶段分布

阶段

试验数

占比

不适用

33.3%

1 期

33.3%

试验状态分布

进行中（未招募）

66.7%

Unknown

33.3%

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

药物批准

PHILIPPINES

Philippines FDA

药物批准

SFDA

Saudi Food and Drug Authority

药物批准

NPRA

National Pharmaceutical Regulatory Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

687

药物批准

近期批准

Canesten HC Cream

NPRA

2025-11-28

CANESTEN-1 VAG. CREAM 10%

SFDA

2025-07-18

CAFINITRINA 1 MG/25 MG COMPRIMIDOS SUBLINGUALES

LUMINALETAS 15 MG COMPRIMIDOS

CIMA_AEMPS

2025-07-14

DOLVIRAN SUPOSITORIOS

CIMA_AEMPS

2025-07-14

PIRAZINAMIDA PRODES 250 mg COMPRIMIDOS

CIMA_AEMPS

2025-07-14

FENTANEST 0,05 mg/ml SOLUCION INYECTABLE

CIMA_AEMPS

2025-07-14

LUMINAL 100 MG COMPRIMIDOS

资讯

暂无资讯文章

返回机构列表

Kern Pharma S.L.

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（3）

Clinical Trial to Investigate the Effectiveness of a Dietary Supplement in Increasing Libido and Sexual Function in Postmenopausal Women.

ew Dosing Systems in Paediatrics.Application to the individualization of the dose of fentanyl in neonatal patients.

ew Dosing Systems in Paediatrics.Application to the individualization of the dose of fentanyl in patients between 1 month and 16 years of age.

药物批准

按机构分类的批准

近期批准

资讯